Skip to main content
. 2022 Jan 13;73(7):2251–2262. doi: 10.1093/jxb/erac008

Fig. 5.

Fig. 5.

Glutamine synthetase (GS) activity of (A) purified yeast recombinant wild-type (WT) and mutant (R59) EiGS1-1 proteins and (B) in leaf extracts of glufosinate-susceptible (EiGS-S) and -resistant (EiGS-R) E. indica plants. Data are means ±SE of three biological replicates per treatment for EiGS-S and EiGS-R samples, and three technical replicates for yeast recombinant EiGS1-1 samples (∗ indicates significant difference according to the t-test, P<0.05).